People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Escalante Bioscience, Inc. | — | Biotech | Series A | $6.7M | $38.1M | 2024 |
Ching-Yun Hsu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ching-Yun Hsu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Akshay R Tambe | 1 | 1 |
| April D Schleck | 1 | 1 |
| Nicholas R Boyd | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.